Business Description
National Health Investors Inc
NAICS : 531120
SIC : 6798
ISIN : US63633D1046
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.91 | |||||
Debt-to-EBITDA | 4.37 | |||||
Interest Coverage | 3.22 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.25 | |||||
Beneish M-Score | -2.48 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -0.3 | |||||
3-Year EBITDA Growth Rate | -5.6 | |||||
3-Year EPS without NRI Growth Rate | -9.1 | |||||
3-Year FCF Growth Rate | -7.1 | |||||
3-Year Book Growth Rate | -4.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 25.19 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.81 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 77.52 | |||||
9-Day RSI | 68.4 | |||||
14-Day RSI | 63.99 | |||||
6-1 Month Momentum % | 22.21 | |||||
12-1 Month Momentum % | 27.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.59 | |||||
Quick Ratio | 4.59 | |||||
Cash Ratio | 0.28 | |||||
Days Sales Outstanding | 99.52 | |||||
Days Payable | 907.35 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 5.75 | |||||
Dividend Payout Ratio | 1.24 | |||||
3-Year Dividend Growth Rate | -6.5 | |||||
Forward Dividend Yield % | 5.75 | |||||
5-Year Yield-on-Cost % | 4.89 | |||||
3-Year Average Share Buyback Ratio | 1.3 | |||||
Shareholder Yield % | 5.99 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 96.4 | |||||
Operating Margin % | 55.9 | |||||
Net Margin % | 42.41 | |||||
FCF Margin % | 57.67 | |||||
ROE % | 10.73 | |||||
ROA % | 5.41 | |||||
ROIC % | 7.39 | |||||
ROC (Joel Greenblatt) % | 528.15 | |||||
ROCE % | 7.81 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-FFO | 14.29 | |||||
PE Ratio | 20.09 | |||||
PE Ratio without NRI | 21.74 | |||||
Shiller PE Ratio | 15.72 | |||||
Price-to-Owner-Earnings | 13.07 | |||||
PS Ratio | 8.5 | |||||
PB Ratio | 2.18 | |||||
Price-to-Tangible-Book | 2.18 | |||||
Price-to-Free-Cash-Flow | 14.77 | |||||
Price-to-Operating-Cash-Flow | 14.77 | |||||
EV-to-EBIT | 20.17 | |||||
EV-to-Forward-EBIT | 18.28 | |||||
EV-to-EBITDA | 14.74 | |||||
EV-to-Forward-EBITDA | 13.08 | |||||
EV-to-Revenue | 11.98 | |||||
EV-to-Forward-Revenue | 10.56 | |||||
EV-to-FCF | 20.77 | |||||
Price-to-Projected-FCF | 0.91 | |||||
Price-to-Median-PS-Value | 0.79 | |||||
Price-to-Graham-Number | 1.45 | |||||
Earnings Yield (Greenblatt) % | 4.96 | |||||
FCF Yield % | 6.75 | |||||
Forward Rate of Return (Yacktman) % | -0.78 |